Thyroid Hormone in CKD patients with diabetes: what is known, what is new
Evidence-based cardiorenal protection in diabetic & non-diabetic CKD
These series’ independent e-seminars are organised by ERBP and supported by AstraZeneca.
3 / 3 results found
Speaker
Roland Schmieder, Germany
Panellists
Michel Burnier, Switzerland
Alberto Ortiz, Spain
Moderator
Pantelis Sarafidis, Greece
ERBP
Click here to register now!
Speaker
Charles Ferro, United Kingdom
Panellists
Mehmet Kanbay, Türkiye
Valerie Luyckx, Switzerland
Moderator
Pantelis Sarafidis, Greece
Thursday, November 14, 2024, at 5:00 PM (CET)
ERBP
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
Speaker
Patrick Mark, United Kingdom
Panellists
Evangelia Dounousi, Greece
Sokratis Stoumpos, United Kingdom
Moderator
Pantelis Sarafidis, Greece
ERBP